Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D07OAH
|
|||
Former ID |
DNC011303
|
|||
Drug Name |
NSC-78021
|
|||
Synonyms |
NSC-78021; CHEMBL1288457; AC1NMT0D; ZINC1713905; BDBM50332194; 4,7-dimethylpyrido[2,3-c]carbazol-4-ium
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C17H15N2+
|
|||
Canonical SMILES |
CN1C2=C(C3=C(C=C2)[N+](=CC=C3)C)C4=CC=CC=C41
|
|||
InChI |
1S/C17H15N2/c1-18-11-5-7-12-14(18)9-10-16-17(12)13-6-3-4-8-15(13)19(16)2/h3-11H,1-2H3/q+1
|
|||
InChIKey |
IAQYIJJPLDSORP-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Quinone reductase 2 (NQO2) | Target Info | Inhibitor | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | In silico identification and biochemical evaluation of novel inhibitors of NRH:quinone oxidoreductase 2 (NQO2). Bioorg Med Chem Lett. 2010 Dec 15;20(24):7331-6. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.